Nitric oxide and chlorhexidine releasing catheter for anti-platelet and antimicrobial dual functionality

A nitric oxide and chlorhexidine impregnated catheter addresses the limitations of current catheters by providing sustained anti-platelet and antimicrobial functionality, effectively inhibiting platelet activation and eradicating biofilms.

AU2020387925B2Pending Publication Date: 2026-07-23BECTON DICKINSON & CO
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
AU2020387925
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-09
Filing Date
2020-11-11
Publication Date
2026-07-23
Estimated Expiration
2040-11-11

AI Technical Summary

Technical Problem

Current catheters lack effective long-term antimicrobial and anti-platelet capabilities, leading to catheter-related bloodstream infections and thrombus formation, and existing anti-thrombogenic technologies are either ineffective or costly.

Method used

A catheter impregnated with a nitric oxide releasing compound and chlorhexidine, manufactured through a multi-step process involving impregnation and dip-coating, to provide simultaneous anti-platelet and antimicrobial properties.

Benefits of technology

The catheter effectively releases nitric oxide and chlorhexidine to inhibit platelet activation and eradicate biofilms, reducing infections and thrombus formation over an extended period.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000001_0000
    Figure 00000001_0000
  • Figure 00000019_0000
    Figure 00000019_0000
Patent Text Reader

Abstract

A catheter configured to release nitric oxide and chlorhexidine providing anti-platelet and antimicrobial properties is manufactured by impregnating a thermoplastic polyurethane catheter extrusion with a nitric oxide releasing compound and with chlorhexidine. Thereafter, the impregnated catheter extrusion is coated with a polyurethane coating comprising chlorhexidine and / or a nitric oxide releasing compound. In the impregnating step, the catheter extrusion may be exposed to a solvent having the nitric oxide releasing compound and chlorhexidine dissolved therein. The solvent is removed from the catheter extrusion. In the coating step, the impregnated catheter extrusion may be dip coated in a polymer solution comprising polyurethane and chlorhexidine and / or a nitric oxide releasing compound in a suitable solvent. The nitric oxide releasing compound, impregnated and / or coated, may be selected from s-nitroso-n-acetylpenicillamine (SNAP), s-nitrosoglutathione (GSNO), and mixtures thereof. The chlorhexidine, impregnated and / or coated, may be selected from chlorhexidine diacetate, chlorhexidine base, chlorhexidine gluconate, and mixtures thereof.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Differential delivery of nitric oxide

    US20040171589A1

  • Medical devices containing nitroprusside and antimicrobial agents

    US20100233288A1

  • Triclosan-containing medical devices

    US6106505A

  • Medical devices containing nitroprusside and antimicrobial agents

    WO2010104760A1

  • Thromboresistant / bactericidal s-nitroso-n-acetylpenicillamine (SNAP)-doped nitric oxide release polymers with enhanced stability

    WO2014124125A2